Lantern Pharma Inc. (LTRN) is a pharmaceutical preparations company incorporated in TX, listed on the Nasdaq. With a market capitalization of $32 million, Lantern Pharma Inc. is a micro-cap company. The stock currently trades at $2.71, down 3.90% today, with a 52-week range of $2.45–$5.74.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.93 | $-1.93 | -31.3% | |
| 2023 | $-1.47 | $-1.47 | -12.2% | |
| 2022 | — | $-1.31 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |